Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkkit: Bengoetxea, Xabier, Rodriguez-Perdigon, Manuel, Ramirez, Maria Javier
Materiálatiipa: Recurso digital
Giella:eaŋgalasgiella
Almmustuhtton: Zenodo 2015
Fáttát:
Liŋkkat:https://doi.org/10.2741/S421
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
_version_ 1866902143776063488
author Bengoetxea, Xabier
Rodriguez-Perdigon, Manuel
Ramirez, Maria Javier
author_facet Bengoetxea, Xabier
Rodriguez-Perdigon, Manuel
Ramirez, Maria Javier
contents <p>Animal models are essential resources in basic research and drug discovery in the field of Alzheimer’s disease (AD). As the main clinical feature in AD is cognitive failure, the ultimate readout for any interventions or the ultimate goal in research should be measures of learning and memory. Although there is a wealth of genetic and biochemical studies on proposed AD pathogenic pathways, the aetiology of the illness remains unsolved. Therefore, assessment by cognitive assays should target relevant memory systems without assumptions about pathogenesis. The description of several tests that are available for assessing cognitive functioning in animal models can be found in literature. Among the behavioural test, the novel object recognition (NOR) task is a method to measure a specific form of recognition memory. It is based on the spontaneous behaviour of rodents and offers the advantage of not needing external motivation, reward or punishment. Therefore, the NOR test has been increasingly used as an experimental tool in assessing drug effects on memory and investigating the neural mechanisms underlying learning and memory. This review describes the basic procedure, modifications, practical considerations, and the requirements and caveats of this behavioural paradigm to be considered as appropriate for the study of AD. Altogether, NOR test could be considered as a very useful instrument that allows researchers to explore the cognitive status of rodents, and hence, for studying AD related pathological mechanisms or treatments.</p>
format Recurso digital
id zenodo_https___doi_org_10_2741_S421
institution Zenodo
language eng
publishDate 2015
publisher Zenodo
record_format zenodo
spellingShingle Object recognition test for studying cognitive impairments in animal models of Alzheimer's disease
Bengoetxea, Xabier
Rodriguez-Perdigon, Manuel
Ramirez, Maria Javier
Transgenic models
Sporadic Alzheimer's disease
Cognition
Amyloid beta
Tau
Review
<p>Animal models are essential resources in basic research and drug discovery in the field of Alzheimer’s disease (AD). As the main clinical feature in AD is cognitive failure, the ultimate readout for any interventions or the ultimate goal in research should be measures of learning and memory. Although there is a wealth of genetic and biochemical studies on proposed AD pathogenic pathways, the aetiology of the illness remains unsolved. Therefore, assessment by cognitive assays should target relevant memory systems without assumptions about pathogenesis. The description of several tests that are available for assessing cognitive functioning in animal models can be found in literature. Among the behavioural test, the novel object recognition (NOR) task is a method to measure a specific form of recognition memory. It is based on the spontaneous behaviour of rodents and offers the advantage of not needing external motivation, reward or punishment. Therefore, the NOR test has been increasingly used as an experimental tool in assessing drug effects on memory and investigating the neural mechanisms underlying learning and memory. This review describes the basic procedure, modifications, practical considerations, and the requirements and caveats of this behavioural paradigm to be considered as appropriate for the study of AD. Altogether, NOR test could be considered as a very useful instrument that allows researchers to explore the cognitive status of rodents, and hence, for studying AD related pathological mechanisms or treatments.</p>
title Object recognition test for studying cognitive impairments in animal models of Alzheimer's disease
topic Transgenic models
Sporadic Alzheimer's disease
Cognition
Amyloid beta
Tau
Review
url https://doi.org/10.2741/S421